| A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury |
APR 2007 |
5 pages |
| Authors:
Deborah L. Warden; HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE ROCKVILLE MD
|
 | The overarching goal of this project is to study the effects of a serotonin reuptake inhibitor (SRI), citalopram, for the treatment of anxiety experienced by individuals after traumatic brain injury (TBI). Specifically, this project seeks to treat individuals who meet criteria for DSM-IV diagnosis of Anxiety Disorder Due to a General Medical Condition, within 3 to 24 months of TBI. A randomized placebo controlled design with 1-year follow-up will be ... |
|
| A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury |
APR 2006 |
6 pages |
| Authors:
Deborah L. Warden; HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE ROCKVILLE MD
|
| The overarching goal of this project is to study the effects of a serotonin reuptake inhibitor (SRI) citalopram for the treatment of anxiety experienced by individuals after traumatic brain injury (TBI). Specifically this project seeks to treat individuals who meet criteria for DSM-IV diagnosis of Anxiety Disorder Due to a General Medical Condition within 6 to 24 months of TBI. A randomized placebo controlled design with i-year follow-up will be ... |
|
| WRAMC DVHIP ANAM Project |
MAY 2005 |
27 pages |
| Authors:
Deborah L. Warden; WALTER REED ARMY MEDICAL CENTER WASHINGTON DC
|
| To examine the construct validity of the Automated Neuropsychological Metrics (ANAM), a computerized neuropsychological test battery. To compare TBI subjects to a comparable sample of controls to examine the effect of TBI and performance predictors and develop normative data. Data analysis completed, manuscript written, and submitted to the Archives of Clinical Neuropsychology. The manuscript is undergoing peer review. This manuscript was attached to the final report from May 2004. 2) ... |
|
| A Randomized Placebo-Controlled Trial of Citalopram for Anxiety Disorders Following Traumatic Brain Injury |
APR 2005 |
6 pages |
| Authors:
Deborah L. Warden; HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE ROCKVILLE MD
|
| The overarching goal of this project is to study the effects of a serotonin reuptake inhibitor (SRI), citalopram, for the - treatment of anxiety experienced by individuals after traumatic brain injury (TBI). Specifically, this project seeks to treat individuals who meet criteria for DSM-IV diagnosis of Anxiety Disorder Due to a General Medical Condition, within 6 to 24 months of TBI. A randomized placebo controlled design with 1-year follow-up will ... |
|
Reports by Author
